T0	Interventions 22 35	immunotherapy
T1	Interventions 111 183	HPV6 L1 virus like particles (VLPs) without adjuvant (VLP immunotherapy)
T2	Interventions 277 284	placebo
T3	Interventions 457 489	conventional destructive therapy
T4	Interventions 525 656	intramuscular administration of 1 µg, 5 µg or 25 µg of VLP immunotherapy, or of placebo immunotherapy (0.9% NaCl), as immunotherapy